ID GPDA_PONAB Reviewed; 349 AA. AC Q5RCE0; DT 28-NOV-2006, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 3. DT 16-JUN-2009, entry version 29. DE RecName: Full=Glycerol-3-phosphate dehydrogenase [NAD+], cytoplasmic; DE Short=GPDH-C; DE Short=GPD-C; DE EC=1.1.1.8; GN Name=GPD1; OS Pongo abelii (Sumatran orangutan). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Pongo. OX NCBI_TaxID=9601; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Kidney; RG The German cDNA consortium; RL Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases. CC -!- CATALYTIC ACTIVITY: sn-glycerol 3-phosphate + NAD(+) = glycerone CC phosphate + NADH. CC -!- SUBUNIT: Homodimer (By similarity). CC -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). CC -!- SIMILARITY: Belongs to the NAD-dependent glycerol-3-phosphate CC dehydrogenase family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; CR858331; CAH90567.1; -; mRNA. DR RefSeq; NP_001125302.1; -. DR UniGene; Pab.19259; -. DR SMR; Q5RCE0; 25-300. DR GeneID; 100172201; -. DR HOVERGEN; Q5RCE0; -. DR OMA; Q5RCE0; THENVKY. DR BRENDA; 1.1.1.8; 269192. DR GO; GO:0009331; C:glycerol-3-phosphate dehydrogenase complex; IEA:InterPro. DR GO; GO:0004367; F:glycerol-3-phosphate dehydrogenase (NAD+) a...; IEA:EC. DR GO; GO:0051287; F:NAD or NADH binding; IEA:InterPro. DR GO; GO:0042803; F:protein homodimerization activity; IEA:InterPro. DR GO; GO:0046168; P:glycerol-3-phosphate catabolic process; IEA:InterPro. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR InterPro; IPR013328; DH_multihelical. DR InterPro; IPR016040; NAD(P)-bd_dom. DR InterPro; IPR006168; NAD-dep_Gly3P_DH. DR InterPro; IPR017751; NAD-dep_Gly3P_DH_euk. DR InterPro; IPR011128; NAD-dep_Gly3P_DH_N. DR InterPro; IPR006109; NAD_Gly3P_DH_C. DR Gene3D; G3DSA:3.40.50.720; NAD(P)-bd; 1. DR Gene3D; G3DSA:1.10.1040.10; Opine_DH; 1. DR PANTHER; PTHR11728; NAD_Gly3P_DH; 1. DR Pfam; PF07479; NAD_Gly3P_dh_C; 1. DR Pfam; PF01210; NAD_Gly3P_dh_N; 1. DR PIRSF; PIRSF000114; Glycerol-3-P_dh; 1. DR PRINTS; PR00077; GPDHDRGNASE. DR ProDom; PD001278; NAD_Gly3P_C; 1. DR TIGRFAMs; TIGR03376; glycerol3P_DH; 1. DR PROSITE; PS00957; NAD_G3PDH; 1. PE 2: Evidence at transcript level; KW Cytoplasm; NAD; Oxidoreductase. FT INIT_MET 1 1 Removed (By similarity). FT CHAIN 2 349 Glycerol-3-phosphate dehydrogenase FT [NAD+], cytoplasmic. FT /FTId=PRO_0000262290. FT NP_BIND 10 15 NAD (By similarity). FT REGION 269 270 Substrate binding (By similarity). FT ACT_SITE 204 204 Proton acceptor (Potential). FT BINDING 41 41 NAD (By similarity). FT BINDING 97 97 NAD (By similarity). FT BINDING 120 120 Substrate (By similarity). FT BINDING 153 153 NAD; via amide nitrogen (By similarity). FT BINDING 269 269 NAD (By similarity). FT BINDING 296 296 NAD; via amide nitrogen (By similarity). FT BINDING 298 298 NAD (By similarity). SQ SEQUENCE 349 AA; 37537 MW; B8FC0A005E326BAF CRC64; MASKKVCIVG SGNWGSAIAK IVGGNAAQLA QFDPRVTMWV FEEDIGGKKL TEIINTQHEN VKYLPGHKLP PNVVAVPDVV QAAADADILI FVVPHQFIGK ICDQLKGHLK ANATGISLIK GVDEGPNGLK LISEVIGEHL GIPMSVLMGA NIASEVADEK FCETTIGCKD PAQGQLLKEL MQTPNFRITV VQEVDTVEIC GALKNVVAVG AGFCDGLGFG DNTKAAVIRL GLMEMIAFAK LFRSGPVSSA TFLESCGVAD LITTCYGGRN RKVAEAFART GKSIEQLEKE LLNGQKLQGP ETARELHSIL QHKGLVDKFP LFMAVYKVCY EGQPVGEFIR CLQNHPEHM //